ArticleHypertension (Dallas, Tex. : 1979)2009
Uncritical acceptance of combination treatment of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in nondiabetic renal disease trial results.
Karen A Griffin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.